Invezz is an independent platform with the goal of helping users achieve financial freedom. In order to fund our work, we partner with advertisers who compensate us for users that Invezz refers to their services. While our reviews and assessments of each product on the site are independent and unbiased, brands may pay to appear higher up our table rankings or place ads in specific areas of the site. The order in which products and services appear on Invezz does not represent an endorsement from us, and please be aware that there may be other platforms available to you than the products and services that appear on our website. Read more about how we make money >
Cardiol Therapeutics Inc (TSE:CRDL)
|Dividend Rate (ttm)||0.0000|
|Trading Day||Oct 25|
|Day's Range||Market Closed|
|52 Week Range||2.32 - 6.19|
NewsNo news found.
Cardiol Therapeutics Inc dividends
Cardiol Therapeutics Inc - Class A has a market cap or net worth of $234.43 million. The enterprise value is $0.
Cardiol Therapeutics Inc - Class A has 43.33 million shares outstanding.
The trailing PE ratio is 0.0000 and the forward PE ratio is -10.0000. Cardiol Therapeutics Inc - Class A's PEG ratio is 0.0000.
Stock Price Statistics
The stock price has increased by 0.9604%. The beta is 0.0000, so Cardiol Therapeutics Inc - Class A's price volatility has been lower than the market average.
In the last 12 months, Cardiol Therapeutics Inc - Class A had revenue of $0 and earned $0 in profits. Earnings per share was $.